Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Interest & Investment Income (2019 - 2025)

Addex Therapeutics' Interest & Investment Income history spans 7 years, with the latest figure at -$1021.3 for Q3 2025.

  • On a quarterly basis, Interest & Investment Income rose 95.22% to -$1021.3 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2437.7, a 109.31% decrease, with the full-year FY2024 number at $30358.8, down 57.9% from a year prior.
  • Interest & Investment Income came in at -$1021.3 for Q3 2025, down from $3.62 in the prior quarter.
  • The five-year high for Interest & Investment Income was $585276.7 in Q1 2021, with the low at -$380537.7 in Q4 2021.
  • Historically, Interest & Investment Income has averaged $6597.6 across 5 years, with a median of $212.85 in 2022.
  • Biggest five-year swings in Interest & Investment Income: tumbled 27489.99% in 2021 and later soared 24941.88% in 2023.
  • Year by year, Interest & Investment Income stood at -$380537.7 in 2021, then skyrocketed by 106.91% to $26310.7 in 2022, then plummeted by 43.74% to $14803.3 in 2023, then soared by 34.29% to $19879.6 in 2024, then tumbled by 105.14% to -$1021.3 in 2025.
  • Business Quant data shows Interest & Investment Income for ADXN at -$1021.3 in Q3 2025, $3.62 in Q2 2025, and -$21299.6 in Q1 2025.